Velleca Mark A.

Director at G1 Therapeutics, Inc.

Sold, on record
$8.9M
Dollars the filings state
Form 4 sales
22
Latest Aug 8, 2023
Form 144 notices
4
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale G1 Therapeutics, Inc.Unusual
    Aug 16, 2022 2022

    Sold 80,000 shares at $12.64 ($1M)

    Velleca Mark A., Director

    Sold 40.8% of holdings ($2.5M position)116,000 shares left2.7x usual sizeFiling

  2. 2 Form 4 sale G1 Therapeutics, Inc.Plan not stated
    Sep 20, 2022 +35 days

    Sold 20,000 shares at $13.50 ($270k)

    Velleca Mark A., Director

    Sold 14.7% of holdings ($1.8M position)116,000 shares left0.7x usual sizeFiling

  3. 3 Form 4 sale G1 Therapeutics, Inc.Plan not stated
    Oct 18, 2022 +28 days

    Sold 15,000 shares at $11.70 ($176k)

    Velleca Mark A., Director

    Sold 11.5% of holdings ($1.5M position)116,000 shares left0.5x usual sizeFiling

  4. 4 Form 144 notice G1 Therapeutics, Inc.Notice
    Aug 8, 2023 +294 days

    Filed to sell 60,000 shares ($120k)

    Velleca Mark A., Director

    10b5-1 plan3x usual sizeFiling

  5. 5 Form 4 sale G1 Therapeutics, Inc.Unusual
    Aug 8, 2023 same day

    Sold 60,000 shares at $2.00 ($120k)

    Velleca Mark A., Director

    10b5-1 planSold 34.1% of holdings ($352k position)116,000 shares left3x usual sizeFollows a Form 144Filing

  6. 6 Form 144 notice G1 Therapeutics, Inc.Notice
    Dec 12, 2023 +126 days

    Filed to sell 60,000 shares ($204k)

    Velleca Mark A., Director

    10b5-1 plan1.5x usual sizeFiling

  7. 7 Form 144 notice G1 Therapeutics, Inc.Notice
    Jan 9, 2024 +28 days

    Filed to sell 60,000 shares ($192k)

    Velleca Mark A., Director

    10b5-1 plan1.5x usual sizeFiling

  8. 8 Form 144 notice G1 Therapeutics, Inc.Notice
    Apr 9, 2024 +91 days

    Filed to sell 28,393 shares ($136k)

    Velleca Mark A., Director

    10b5-1 plan0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (26)

Form 144 notices and Form 4 sales by Velleca Mark A.
Source
Apr 9, 2024Apr 9, 2024G1 Therapeutics, Inc.DirectorForm 144 notice28,393$136kNoticeSEC
Jan 9, 2024Jan 9, 2024G1 Therapeutics, Inc.DirectorForm 144 notice60,000$192kNoticeSEC
Dec 12, 2023Dec 12, 2023G1 Therapeutics, Inc.DirectorForm 144 notice60,000$204kNoticeSEC
Aug 8, 2023Aug 10, 2023G1 Therapeutics, Inc.DirectorForm 4 sale60,000$120k34.1%UnusualSEC
Aug 8, 2023Aug 8, 2023G1 Therapeutics, Inc.DirectorForm 144 notice60,000$120kNoticeSEC
Oct 18, 2022Oct 20, 2022G1 Therapeutics, Inc.DirectorForm 4 sale15,000$176k11.5%Plan not statedSEC
Sep 20, 2022Sep 22, 2022G1 Therapeutics, Inc.DirectorForm 4 sale20,000$270k14.7%Plan not statedSEC
Aug 16, 2022Aug 18, 2022G1 Therapeutics, Inc.DirectorForm 4 sale80,000$1M40.8%UnusualSEC
Jul 15, 2021Jul 15, 2021G1 Therapeutics, Inc.DirectorForm 4 sale30,000$570k33.0%UnusualSEC
Jun 17, 2021Jun 17, 2021G1 Therapeutics, Inc.DirectorForm 4 sale30,000$659k33.0%UnusualSEC
May 13, 2021May 13, 2021G1 Therapeutics, Inc.DirectorForm 4 sale30,000$597k42.3%UnusualSEC
Apr 15, 2021Apr 15, 2021G1 Therapeutics, Inc.DirectorForm 4 sale30,000$734k42.3%UnusualSEC
Feb 18, 2021Feb 18, 2021G1 Therapeutics, Inc.DirectorForm 4 sale31,040$925k43.1%UnusualSEC
Jan 21, 2021Jan 21, 2021G1 Therapeutics, Inc.DirectorForm 4 sale30,000$630k42.3%UnusualSEC
Dec 17, 2020Dec 17, 2020G1 Therapeutics, Inc.President and CEOForm 4 sale30,000$586k44.8%UnusualSEC
Nov 15, 2018Nov 16, 2018G1 Therapeutics, Inc.President and CEOForm 4 sale5,000$199k20.8%Plan not statedSEC
Oct 15, 2018Oct 15, 2018G1 Therapeutics, Inc.President and CEOForm 4 sale5,000$208k20.8%Plan not statedSEC
Sep 17, 2018Sep 19, 2018G1 Therapeutics, Inc.President and CEOForm 4 sale5,000$332k35.7%UnusualSEC
Aug 15, 2018Aug 17, 2018G1 Therapeutics, Inc.President and CEOForm 4 sale5,000$279k35.7%UnusualSEC
Jul 16, 2018Jul 17, 2018G1 Therapeutics, Inc.President and CEOForm 4 sale5,000$210k35.7%UnusualSEC
May 15, 2018May 16, 2018G1 Therapeutics, Inc.President and CEOForm 4 sale7,500$347k100.0%UnusualSEC
Apr 16, 2018Apr 17, 2018G1 Therapeutics, Inc.President and CEOForm 4 sale7,500$270k100.0%UnusualSEC
Mar 15, 2018Mar 16, 2018G1 Therapeutics, Inc.President and CEOForm 4 sale7,500$287k100.0%UnusualSEC
Feb 15, 2018Feb 16, 2018G1 Therapeutics, Inc.President and CEOForm 4 sale7,500$150k100.0%UnusualSEC
Jan 16, 2018Jan 17, 2018G1 Therapeutics, Inc.President and CEOForm 4 sale7,500$172k100.0%UnusualSEC
Dec 18, 2017Dec 20, 2017G1 Therapeutics, Inc.President and CEOForm 4 sale7,500$150k100.0%UnusualSEC